Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

FBC predisposition

Financiado

Cerrado

Unraveling novel Familial Breast Cancer FBC predisposition genes.

Breast cancer is the most common cancer in women worldwide. Familial breast cancer (FBC) is expected to account for up to 15% of breast cancers. Although recent breakthroughs have resulted in the identification of distinct new gro... ver más

17/12/2022

UCPH

219K€

Presupuesto del proyecto: 219K€

Líder del proyecto

KOBENHAVNS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-12-17

MSCA-IF-2019: Individual Fellowships

I+D

Cerrada hace 5 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UCPH

219.31K€ | Lider

Proyectos interesantes

DREMATURE

Medical Technol...

Data Science

187K€ Cerrado

GenCaR

Medical Technol...

Data Science

100K€ Cerrado

SAF2010-20493

Medical Technol...

Data Science

97K€ Cerrado

SAF2014-57680-R

Medical Technol...

Data Science

97K€ Cerrado

DISSECTING BRCA2

Medical Technol...

Data Science

100K€ Cerrado

SYNTHLE BRCA

Medical Technol...

Data Science

169K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 33 meses Fecha Inicio: 2020-02-25
Fecha Fin: 2022-12-17

Líder del proyecto

KOBENHAVNS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 219K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Breast cancer is the most common cancer in women worldwide. Familial breast cancer (FBC) is expected to account for up to 15% of breast cancers. Although recent breakthroughs have resulted in the identification of distinct new groups of genetically inherent breast cancer genes, about 64% of the genetic predisposition to FBC remains unexplained. Therefore, new approaches are required to identify remaining genetic factors underlying FBC susceptibility. This is crucial because the elucidation of inherent cancer defects offers the ability to counsel and monitor patients. Importantly, it also provides firm ground for therapeutically targeting particular cancer pathways for example through Poly ADP-ribose polymerase inhibitors (PARPi) that exploit synthetic lethality with particular DNA repair deficiencies. To advance the field, my host lab has performed High-Throughput phenotypic screen, based on gene variants recognized in a FBC cohort of 135 early-onset (age <35 years) breast cancer patients through whole exome sequencing. The 270 new genes with potential disease association were enrolled in screens, focusing on genome maintenance and PARPi sensitivity. These unique preliminary data form the basis for my project. I hypothesize that by performing following specific analyses I will be able to elucidate new FBC predisposition genes: •Ranking of screen hits by performing FBC-associated variant analysis in an international and Danish FBC cohort. •Elucidating molecular function of novel FBC predisposition genes in genome maintenance. •Unraveling the molecular network of candidate proteins by unbiased Mass-spectrometry as well as follow-up analysis of interactors. I anticipate that my work will provide novel FBC predisposition genes, which will markedly contribute to clinical risk assessment tools (such as targeted sequencing) by ensuring identification of individuals at elevated risk who benefit from advances in surveillance and targeted interventions.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores